James Vath is an Investor at Cure Ventures, whose known portfolio counts 7 companies.
Is James Vath a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCompany BuildingDrug DiscoveryGenomicsTherapeutics
Contacts
Affiliated funds' portfolios
Investor at Cure Ventures, whose known portfolio counts 7 companies
- Kenai Therapeutics
- Red Arrow Therapeutics
- Tortugas Neuroscience
- Clasp Therapeutics
- GenKardia
- Sidereal Therapeutics
- Tasca
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Company Building, Drug Discovery and Genomics. Startups operating in these areas may find James Vath relevant.
Stage-wise, the deals at Cure Ventures cluster around Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether James Vath is worth approaching.
Colleagues at Cure Ventures
Lou Tartaglia
Managing Partner and Co-Founder
Boston, United States
Annie Mitsak
Partner
Boston, United States
Drew King
Partner and Chief Financial Officer
Boston, United States
May Han
Partner
Brookline, United States
Kenzie MacIsaac
Partner
Boston, United States
Milenko Cicmil
Partner
Boston, United States
David Fallace
Managing Partner and Co-founder
Boston, United States
Albert J Robichaud
Partner
Cambridge, United States
Bill Amsbaugh
Partner
Cambridge, United States
Frequently asked questions
Who is James Vath?
James Vath is an accelerator partner and venture capital investor based in Boston, Massachusetts, United States, listed as Investor at Cure Ventures. The known portfolio of that firm counts 7 companies. That portfolio belongs to the firm, not to James Vath personally.
What does James Vath invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Company Building, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does James Vath invest at?
Cure Ventures appears in Seed and Series A rounds across its known deals, and James Vath is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is James Vath listed at?
James Vath is listed as Investor at Cure Ventures. 9 other people in the database share a firm with James Vath.
How do I contact James Vath?
A LinkedIn page is on file for James Vath. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal